Skip to content

Commit

Permalink
bump version
Browse files Browse the repository at this point in the history
  • Loading branch information
Lucpen committed Apr 25, 2024
1 parent fa54f5d commit d5d3189
Show file tree
Hide file tree
Showing 3 changed files with 4 additions and 3 deletions.
3 changes: 2 additions & 1 deletion CHANGELOG.md
Original file line number Diff line number Diff line change
Expand Up @@ -14,7 +14,7 @@ Parameter has been added if just the new parameter information is present.
Parameter has been removed if new parameter information isn't present.
:::

## 2.0.2 - Grinch [XXXX-XX-XX]
## 2.0.2 - [XXXX-XX-XX]

### `Added`

Expand All @@ -27,6 +27,7 @@ Parameter has been removed if new parameter information isn't present.
### `Added`

### `Fixed`

- Vep annotated research results will be published [#115](https://github.com/genomic-medicine-sweden/tomte/pull/115)

### `Parameters`
Expand Down
2 changes: 1 addition & 1 deletion assets/multiqc_config.yml
Original file line number Diff line number Diff line change
@@ -1,5 +1,5 @@
report_comment: >
This report has been generated by the <a href="https://github.com/genomic-medicine-sweden/tomte/releases/tag/2.0.0" target="_blank">genomic-medicine-sweden/tomte</a>
This report has been generated by the <a href="https://github.com/genomic-medicine-sweden/tomte/releases/tag/2.0.1" target="_blank">genomic-medicine-sweden/tomte</a>
analysis pipeline. For information about how to interpret these results, please see the
<a href="https://github.com/genomic-medicine-sweden/tomte/blob/master/docs/output.md" target="_blank">documentation</a>.
report_section_order:
Expand Down
2 changes: 1 addition & 1 deletion nextflow.config
Original file line number Diff line number Diff line change
Expand Up @@ -270,7 +270,7 @@ manifest {
description = """Pipeline to analyse RNAseq from raredisease patients"""
mainScript = 'main.nf'
nextflowVersion = '!>=23.04.0'
version = '2.0.0'
version = '2.0.1'
doi = '10.5281/zenodo.10828946'
}

Expand Down

0 comments on commit d5d3189

Please sign in to comment.